Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
123I-5-IA SPECT Imaging of Nicotinic Receptors and Effects of Nicotine Vaccine
NCT00996034Phase 2Completed
- Sponsor
- Yale University
- Start
- Sep 2009
- Primary completion
- Feb 2011
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of NicVAX in nicotine dependence, sponsored by Yale University. Started Sep 2009; status: completed.
02
Drugs
NicVAX
03
Conditions
nicotine dependence
Beyond the preview
Go deeper on NCT00996034.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00996034.